Prostate disorder
MONDO:0003105A disease involving the prostate gland.
Also known as: disease of prostate gland, disease or disorder of prostate gland, disorder of prostate gland, prostate disease, prostate disorder, prostate gland disease, prostate gland disease or disorder
2439 clinical trials for this condition and its sub-types, 16 tagged with Prostate disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Prostate disorder
-
Prostate neoplasm 124 trials · 2,225 incl. sub-types
5 sub-types
- Prostate cancer 1,913 trials · 2,217 incl. sub-types Sub-types →
- Prostate neuroendocrine neoplasm 20 trials · 25 incl. sub-types Sub-types →
- Prostate intraepithelial neoplasia 2 trials Sub-types →
- Benign neoplasm of prostate 0 trials Sub-types →
- Prostate phyllodes tumor 0 trials Sub-types →
-
Benign prostatic hyperplasia 225 trials
-
Prostatitis 4 trials · 15 incl. sub-types
5 sub-types
- Chronic prostatitis 14 trials
- Trichomonas prostatitis 0 trials
- Gonococcal prostatitis 0 trials Sub-types →
- Granulomatous prostatitis 0 trials
- Prostatocystitis 0 trials
-
Prostate calculus 0 trials
-
Prostatic cyst 0 trials
Most studied deeper sub-types
-
One-shot hormone blocker may prevent repeat urinary blockages in men
Disease control Not yet recruitingThis phase 2 trial tests whether a single injection of teverelix DP, a hormone-blocking drug, can shrink the prostate and improve urinary function in men who recently experienced a first episode of acute urinary retention due to an enlarged prostate. About 126 men aged 45 and old…
Phase 2 • Sponsor: Antev Ltd. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New drug aims to starve prostate cancer by blocking testosterone
Disease control Not yet recruitingThis phase 2 trial tests a drug called teverelix DP in 40 men with advanced prostate cancer. The drug works by blocking a hormone that tells the body to make testosterone, which can fuel cancer growth. The goal is to see if a specific dosing schedule can safely lower testosterone…
Phase 2 • Sponsor: Antev Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC